Patents by Inventor Grzegorz Kurzawski

Grzegorz Kurzawski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DETERMINING REDUCED PREDISPOSITION TO CANCER BASED ON GENETIC PROFILE
    Publication number: 20110105342
    Abstract: The invention provide methods for early detection of a reduced risk of developing cancer, which comprises detecting the absence of a series of genetic polymorphisms associated with a predisposition of developing cancer, including the polymorphisms of the genes BRCA1, BRCA2, CARD15 (NOD2), CHEK2, CDKN2A (P16), CYP1B1, FGFR2 (KGFR2), MAP3K1 (MEKK1), p53 (TP53), TNRC9, XPD (ERCC2) and the genetic marker Rs6983267, in a biological sample from the analyzed subject, wherein the absence of the genetic polymorphisms is indicative of significantly decreased risk of developing, at least, breast cancer.
    Type: Application
    Filed: March 13, 2009
    Publication date: May 5, 2011
    Inventors: Jan Lubinski, Tadeusz Debniak, Grzegorz Kurzawski, Anna Jakubowska, Krzystof Medrek, Cezary Cybulski, Jacek Gronwald, Tomasz Huzarski, Bohdan Gorski, Tomasz Byrski, Joanna Matyjasik, Pablo Serrano Fernandez
  • Determining a predisposition to cancer
    Patent number: 7851162
    Abstract: The present invention relates to methods and kits for determining a predisposition and surveillance protocols for developing cancer of various sites due to specific mutation in at least one allele of CHEK2 gene and/or at least one allele of NOD2 gene and/or at least one allele of CDKN2A gene.
    Type: Grant
    Filed: July 28, 2008
    Date of Patent: December 14, 2010
    Inventors: Jan Lubiñski, Janina Suchy, Grzegorz Kurzawski, Tadeusz Dêbniak, Cezary Cybulski
  • Determining a predisposition to cancer
    Publication number: 20090092984
    Abstract: The present invention relates to methods and kits for determining a predisposition and surveillance protocols for developing cancer of various sites due to specific mutation in at least one allele of CHEK2 gene and/or at least one allele of NOD2 gene and/or at least one allele of CDKN2A gene.
    Type: Application
    Filed: July 28, 2008
    Publication date: April 9, 2009
    Inventors: Jan Lubinski, Janina Suchy, Grzegorz Kurzawski, Tadeusz Debniak, Cezary Cybulski
  • Determining a predisposition to cancer
    Patent number: 7407755
    Abstract: The present invention relates to methods and kits for determining a predisposition and surveillance protocols for developing cancer of various sites due to specific mutation in at least one allele of CHEK2 gene and/or at least one allele of NOD2 gene and/or at least one allele of CDKN2A gene.
    Type: Grant
    Filed: January 18, 2005
    Date of Patent: August 5, 2008
    Inventors: Jan Lubiñski, Janina Suchy, Grzegorz Kurzawski, Tadeusz Dêbniak, Cezary Cybulski
  • Determining a predisposition of cancer
    Publication number: 20050191669
    Abstract: The present invention relates to methods and kits for determining a predisposition and surveillance protocols for developing cancer of various sites due to specific mutation in at least one allele of CHEK2 gene and/or at least one allele of NOD2 gene and/or at least one allele of CDKN2A gene.
    Type: Application
    Filed: January 18, 2005
    Publication date: September 1, 2005
    Inventors: Jan Lubinski, Janina Suchy, Grzegorz Kurzawski, Tadeusz Debniak, Cezary Cybulski